HepaLife Technologies
 
Home Corporate Bioartificial Liver Clinical Trials Investors Contact

Corporate Governance

HepaLife Technologies, Inc. is committed to the highest standards of ethical behavior and the Company's commitment extends to all aspects of its role as an employer and as a corporate citizen. This commitment to ethical behavior extends beyond mere compliance with laws and regulations to inspire our relationships with our shareholders, clients, and employees.

HepaLife Technologies, Inc. has a code of conduct known as, "Code of Corporate Governance And Ethics" that applies to all employees, officers and directors of the company and its subsidiaries and affiliates. This document can be downloaded via the link provided below and is also available free of charge upon request in writing to our address at 850 3rd Avenue, Suite 1801, New York, NY 10022 or by using our website form (click here) to email us.

Bullet Communications with Shareholders
Shareholders and other interested persons are invited to call HepaLife Investor Relations at 1-800-518-4879. Written correspondence should be addressed to Investor Relations at our address at: 850 3rd Avenue, Suite 1801, New York, NY 10022 by using our website form (click here) to email us.